Hispril

   
Google
 
Web NewDrugInformation.com

Hispril


Drug - Hispril
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Diphenylpyraline Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 5MG
The potency of the active ingredient(s), Diphenylpyraline Hydrochloride. May repeat for multiple part products.

Applicant - GLAXOSMITHKLINE
The firm name holding legal responsibility for Hispril. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 011945
The FDA assigned number to Hispril. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Hispril. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Hispril was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hispril. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Hispril is in. Format is RX, OTC, DISCN.

Applicant Full Name - Glaxosmithkline
The full name of the firm holding legal responsibility for the new application of Hispril.

Hispril